Japan's Astellas Pharma Inc. said on Friday it had won a suit against Ranbaxy Laboratories Ltd. to prevent the Indian drug maker from releasing an early generic version of its Flomax prostate drug. Astellas, Japan's third-largest drug maker and Germany's Boehringer Ingelheim, which jointly market the drug in the United States, had filed the suit at the U.S. District Court of New Jersey. The U.S. patent on Flomax, used to treat enlarged prostates, expires in Oct. 2009

Posted by GEN-ERIC at 12:03:04 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/1056

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)